Vitamin C is NOT indicated for recurrent epistaxis
Vitamin C supplementation should not be routinely used for the treatment or prevention of recurrent epistaxis. The most recent and authoritative guideline on epistaxis management from the American Academy of Otolaryngology-Head and Neck Surgery (2020) does not recommend vitamin C as a treatment modality 1.
Evidence-Based Management of Recurrent Epistaxis
The 2020 AAO-HNS clinical practice guideline provides clear, evidence-based interventions for recurrent epistaxis that do NOT include vitamin C:
First-Line Preventive Measures
- Nasal moisturization: Saline gels or sprays 1-3 times daily
- Humidification: Bedside humidifier use
- Behavioral modifications: Eliminate digital trauma (nose picking) and vigorous nose blowing 1
Treatment for Identified Bleeding Sites
The guideline specifically recommends:
- Topical vasoconstrictors (oxymetazoline, phenylephrine)
- Nasal cautery (chemical or electrocautery)
- Moisturizing or lubricating agents 1
When to Escalate Care
For recurrent bleeding despite conservative measures:
- Evaluate for surgical arterial ligation or endovascular embolization
- Assess for underlying pathology (nasal telangiectasias, hereditary hemorrhagic telangiectasia) in patients with recurrent bilateral nosebleeds or family history 1
Why Vitamin C Is Not Recommended
The absence of vitamin C from the comprehensive 2020 epistaxis guideline is telling. This guideline underwent rigorous evidence review and explicitly lists research gaps—vitamin C is not even mentioned as a potential therapy requiring further study 1.
The Only Exception: True Vitamin C Deficiency (Scurvy)
Vitamin C supplementation is indicated ONLY when:
- Clinical scurvy is suspected (bleeding, petechiae, ecchymosis with documented deficiency)
- Plasma vitamin C levels are measured and confirmed low (<11 μmol/L)
- Dosing for deficiency: 200-500 mg/day orally for malabsorption states 2, 3
This is an entirely different clinical scenario than routine recurrent epistaxis. One case report describes a patient with Crohn's disease and myasthenia gravis requiring high-dose IV vitamin C for bleeding symptoms, but this was in the context of documented severe deficiency and malabsorption 3—not applicable to typical epistaxis patients.
Clinical Algorithm for Recurrent Epistaxis
Document risk factors: Anticoagulation use, hypertension, digital trauma, environmental dryness 1
Implement preventive measures:
- Nasal saline gel/spray 1-3 times daily
- Bedside humidifier
- Eliminate nose picking and vigorous blowing
Identify bleeding site via anterior rhinoscopy or nasal endoscopy 1
Treat identified site:
- Topical vasoconstrictors
- Cauterization (restrict to active bleeding site only)
- Continue moisturizing agents
If bleeding persists: Refer for surgical intervention or embolization 1
Screen for underlying conditions: Consider hereditary hemorrhagic telangiectasia if bilateral recurrent bleeds or positive family history 1
Common Pitfalls to Avoid
- Do not recommend vitamin C supplementation as a preventive or therapeutic measure for routine epistaxis—there is no evidence supporting this practice
- Do not delay appropriate interventions (cautery, packing, surgical referral) in favor of unproven supplements
- Do not measure vitamin C levels unless clinical scurvy is genuinely suspected based on systemic bleeding manifestations and risk factors for deficiency 2
The evidence is clear: stick to proven interventions—nasal moisturization, vasoconstrictors, cautery, and appropriate escalation when needed.